Press Release: SL Pharm : Research and Markets: Investigation Report on China's Atorvastatin Market, 2010-2019 Featuring Ebang Pharmaceutical, Pfizer, Topfond & Beijing Jialin Pharmaceutical

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/j9xzkk/investigation) has announced the addition of the "Investigation Report on China's Atorvastatin Market, 2010-2019" report to their offering. With the change of lifestyles brought about by the economic development and the rising incomes, the number of hyperlipidemia patients in China keeps growing, being estimated to reach 160-200 million in the near future. Atorvastatin, a common drug that can lower